Zhang Huizhe, Wang Xue, Shi Yanchen, Liu Mengying, Xia Qingqing, Jiang Weilong, Zhang Yufeng
Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
Department of Respiratory Medicine, Yancheng Hospital of Traditional Chinese Medicine, Yancheng Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu 224005, China.
Evid Based Complement Alternat Med. 2022 Apr 26;2022:3439656. doi: 10.1155/2022/3439656. eCollection 2022.
To develop a putative microRNA (miRNA) and messenger RNA (mRNA) regulatory network of Danggui Buxue decoction's (DGBXD) amelioration of idiopathic pulmonary fibrosis (IPF).
The Gene Expression Omnibus (GEO) database was used to identify differentially expressed miRNAs (DE-miRNAs) and differentially expressed mRNAs (DE-mRNAs). Using miRNet, the predicted target genes of identified DE-miRNAs were estimated, and then the target genes of DE-miRNAs in IPF were comprehensively examined. The Enrichr database was used to conduct functional enrichment and pathway enrichment. Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) was employed to obtain the target genes of DGBXD as well as active compounds. A putative miRNA-mRNA regulatory network of DGBXD acting on IPF was developed by intersecting the target genes of DGBXD with the DE-miRNA target genes in IPF. A bleomycin-induced mouse model was established and used to perform histopathology as well as real-time quantitative polymerase chain reaction (qRT-PCR) analyses of some miRNA-mRNA pairs.
Fourteen upmodulated DE-miRNAs and six downmodulated DE-miRNAs were screened. The downstream target genes of upmodulated and downmodulated DE-miRNAs were predicted. Subsequently, 1160 upmodulated DE-mRNAs and 1427 downmodulated DE-mRNAs were identified. Then, target genes of DE-miRNAs comprising 49 downmodulated and 53 upmodulated target genes were further screened to perform functional enrichment and pathway enrichment analyses. Subsequently, 196 target genes of DGBXD were obtained from TCMSP, with six downregulated target genes and six upregulated target genes of DGBXD acting on IPF being identified. A promising miRNA-mRNA regulatory network of DGBXD acting on IPF was developed in this study. Moreover, mir-493 together with its target gene Olr1 and mir-338 together with Hif1a were further validated by qRT-PCR.
This study proposed detailed possible processes of miRNA-mRNA modulatory axis in IPF and constructed a prospective IPF-related miRNA-mRNA modulatory network with the aim of alleviating IPF with DGBXD.
构建当归补血汤(DGBXD)改善特发性肺纤维化(IPF)的潜在微小RNA(miRNA)与信使核糖核酸(mRNA)调控网络。
利用基因表达综合数据库(GEO)鉴定差异表达的miRNA(DE-miRNA)和差异表达的mRNA(DE-mRNA)。使用miRNet评估已鉴定的DE-miRNA的预测靶基因,然后全面检查IPF中DE-miRNA的靶基因。利用Enrichr数据库进行功能富集和通路富集。采用中药系统药理学数据库与分析平台(TCMSP)获取DGBXD的靶基因以及活性成分。通过将DGBXD的靶基因与IPF中DE-miRNA的靶基因相交,构建DGBXD作用于IPF的潜在miRNA-mRNA调控网络。建立博来霉素诱导的小鼠模型,用于对一些miRNA-mRNA对进行组织病理学以及实时定量聚合酶链反应(qRT-PCR)分析。
筛选出14个上调的DE-miRNA和6个下调的DE-miRNA。预测上调和下调的DE-miRNA的下游靶基因。随后,鉴定出1160个上调的DE-mRNA和1427个下调的DE-mRNA。然后,进一步筛选包含49个下调和53个上调靶基因的DE-miRNA的靶基因,以进行功能富集和通路富集分析。随后,从TCMSP获得196个DGBXD的靶基因,鉴定出6个下调的DGBXD靶基因和6个上调的DGBXD作用于IPF的靶基因。本研究构建了一个有前景的DGBXD作用于IPF的miRNA-mRNA调控网络。此外,通过qRT-PCR进一步验证了mir-493及其靶基因Olr1以及mir-338及其靶基因Hif1a。
本研究提出了IPF中miRNA-mRNA调控轴的详细可能过程,并构建了一个前瞻性的IPF相关miRNA-mRNA调控网络,旨在用DGBXD缓解IPF。